Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Little more than a month after making specious claims that there’s a link between Tylenol use and autism, Health and Human ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

Dow Jones Top Financial Services Headlines at 4 PM ET: Apollo Invests $75 Billion in Quarter As Firm Continues to Grow Deal Capacity | Sequoia ... Apollo Invests $75 Billion in Quarter As Firm ...

Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...

The record dropped the same week that Pope John Paul II and Palestine leader Yasser Arafat came together for their historic ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Hospitals across Baltimore are seeing an increase in patients but cannot point to a particular illness as the cause.

Many expectant moms are unaware of the dangers of cannabis use.

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...